On the morning of July 27, 2022, the signing ceremony of strategic cooperation between Zhejiang Longcharm Biomedical Technology Co., Ltd. and Hangzhou Yibo Health Management Co., Ltd. was held in Hangzhou, Zhejiang Province. Both sides reached an agreement on in-depth cooperation in the fields of generic drugs BA/BE, new drugs PK and Phase I clinical research. Zhang Zhen, General Manager of Longcharm Biotech, Liming, Deputy General Manager of Longcharm Biotech BE Business Department, Chen Jian, Operation Director of Yibo Health Clinical Research Center, Cao Xiaochun, Co founder and President of Hangzhou Taige Medical Technology Co., Ltd., Zhao Dandan, Director of the Institutional Office of Hangzhou Compaq Hospital, Deng Yaping, Secretary of the Institutional Office of Zhejiang Xiaoshan Hospital, and other representatives attended the signing ceremony.

At the signing ceremony, Dr. Zhang Zhen and Dr. Chen Jian signed a strategic cooperation framework agreement on behalf of Long Chuan Bio and Yibai Health. The two sides said that the two enterprises have broad space for cooperation in the field of clinical research. The two sides will further focus on the implementation of drug clinical research business under the new situation, fully integrate the advantages of Longcharm Bio in innovative drug incubation, international double reporting BE/PK services, and the resource advantages of the clinical research center under Yibai Health, so as to achieve complementary advantages, strong alliance, and mutual benefit and win-win results.